Racked is no longer publishing. Thank you to everyone who read our work over the years. The archives will remain available here; for new stories, head over to Vox.com, where our staff is covering consumer culture for The Goods by Vox. You can also see what we’re up to by signing up here.
The FDA has finally approved the use of Botox to treat chronic migraines in adults. Patients will continue shooting it into their armpits and feet to prevent sweating and high-heel pain, respectively. [NPR]